methylnitrosourea has been researched along with nimesulide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM | 1 |
Ahn, B; Hahm, KB; Han, SU; Jang, DD; Kang, JS; Kim, DY; Kim, YB; Nam, KT; Oh, SY; Yang, KH; Yeo, M | 1 |
1 review(s) available for methylnitrosourea and nimesulide
Article | Year |
---|---|
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Humans; Methylnitrosourea; Mice; NF-kappa B; Quinolones; Stomach Neoplasms; Sulfonamides | 2003 |
1 other study(ies) available for methylnitrosourea and nimesulide
Article | Year |
---|---|
The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; In Situ Nick-End Labeling; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Sulfonamides | 2004 |